A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis

Abstract

HIV-1 CRF01_AE and subtype B (B) have dominated and their different circulating recombinant forms (CRFs) have emerged in East and Southeast Asian countries. Here, we report a novel drug-resistant HIV-1 CRF. Five independent recombinant specimens exhibiting discordant subtype results for the gag, pol, and env sequences were isolated. These recombinants had the CRF01_AE (gag p17)/B (pol PR-RT and IN)/CRF01_AE (env C2-V3) pattern similar to CRF69_01B. Sequence analysis of four near full-length HIV-1 genomes revealed a unique phylogenetic cluster distinct from previously reported CRFs. Of the four recombinants, three shared an identical mosaic structure including seven breakpoints in the gag, pol, vif, and env regions, designated CRF76_01B. The one remaining recombinant had additional recombination breakpoints in the vpu region and exhibited another unique recombinant form composed of CRF76_01B and B. These findings provide important insight into the transmission dynamics of HIV-1 in Asia that may be important for its effective prevention.

Get full access to this article

View all access options for this article.

References

Hattori

, Shiino

, Gatanaga

, et al.: Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: Nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res, 2010; 88(1):72–79.

Gatanaga

, Ibe

, Matsuda

, et al.: Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan. Antiviral Res, 2007; 75(1):75–82.

Shiino

, Hattori

, Yokomaku

, et al. and the Japanese Drug Resistance HIVSN: Phylodynamic analysis reveals CRF01_AE dissemination between Japan and neighboring Asian countries and the role of intravenous drug use in transmission. PLoS One, 2014; 9(7):e102633.

Kusagawa

, Yokota

, Negishi

, et al.: Novel HIV-1 recombinant identified in a foreign heterosexual resident in Japan: Relatedness to recently reported CRF69_01B, detected primarily among Japanese men who have sex with men. Genome Announc, 2015; 3(3).

Hosaka

, Fujisaki

, Hattori

, et al.: CRF01_AE and subtype B transmission networks cross over: A new AE-B recombinant emerges in Japan. 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2014, 229.

Robertson

, Anderson

, Bradac

, et al.: HIV-1 nomenclature proposal. Science, 2000; 288(5463):55–56.

Ode

, Matsuoka

, Matsuda

, et al.: HIV-1 near full-length genome analysis by next-generation sequencing: Evaluation of quasispecies and minority drug resistance. International Workshop on Antiviral Drug Resistance: Meeting the Global Challenge. Vol. 19. Berlin, Germany. Antiviral Therapy, 2014, A80.

Hachiya

, Ode

, Matsuda

, et al.: Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance. Antiviral Res, 2015; 119:84–88.

Lole

, Bollinger

, Paranjape

, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol, 1999; 73(1):152–160.

10.

Schultz

, Zhang

, Bulla

, et al.: jpHMM: Improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res, 2009; 37(Web Server issue):W647–651.

11.

Lau

and Wong

: Current trends of HIV recombination worldwide. Infect Dis Rep, 2013; 5(Suppl 1):e4.

12.

and Kuritzkes

: Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors. J Virol, 2014; 88(16):9268–9276.

13.

Wensing

, Calvez

, Gunthard

, et al.: 2014 Update of the drug resistance mutations in HIV-1. Top Antivir Med, 2014; 22(3):642–650.